STRATA CRITICAL MEDICAL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $119.63M, a 2002142.68% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $100.16K.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $5.97K.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, new issues for fiscal 2021 was $119.63M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $119.63M 10-K · filed 2023-03-16 |
| 2021-06-30 | $119.63M 10-Q · filed 2022-08-09 | |
| 2020-09-30 | $100.16K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $5.97K 10-Q · filed 2020-11-10 | |
| 2020-03-31 | -$572.07K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |